{"name":"CRG UZ Brussel","slug":"crg-uz-brussel","ticker":"","exchange":"","domain":"","description":"CRG UZ Brussel is a specialized pharmaceutical company focused on the development and commercialization of innovative treatments in reproductive health. The company has a portfolio of three key drugs, including Corifollitoropin alfa (CFA) which is already marketed.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5vcHJzUEs3a1I4akVMRnI0U2R5RC0zWGoteUtWeGQxZWV5N1RySFVfWTExMlRyN3ZPTTk2R2JpamZMOHdTMU03ZDljUGg2d1U3MGl6anFMdVFxWGtnc3BPZlNacTlGMUFoYWZRWnVB?oc=5","date":"2024-03-01","type":"pipeline","source":"American Heart Association Journals","summary":"Genetic Testing in Brugada Syndrome: A 30-Year Experience | Circulation: Arrhythmia and Electrophysiology - American Heart Association Journals","headline":"Genetic Testing in Brugada Syndrome: A 30-Year Experience | Circulation: Arrhythmia and Electrophysiology","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}